ArticleNeoplasia (New York, N.Y.)2021

Imbalance between genomic gain and loss identifies high-risk neuroblastoma patients with worse outcomes.

Beatriz Fernández-Blanco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.